MICHELLE A FANALE to Receptor, ErbB-2
This is a "connection" page, showing publications MICHELLE A FANALE has written about Receptor, ErbB-2.
Connection Strength
0.029
-
Combination therapy of Ad-mda7 and trastuzumab increases cell death in Her-2/neu-overexpressing breast cancer cells. Surgery. 2004 Aug; 136(2):437-42.
Score: 0.029